Company registration number 11889951 (England and Wales)
H2 MEDICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022
PAGES FOR FILING WITH REGISTRAR
H2 MEDICAL LTD
CONTENTS
Page
Balance sheet and notes to the financial statements
1 - 2
H2 MEDICAL LTD
BALANCE SHEET
AS AT
31 MARCH 2022
31 March 2022
- 1 -
2022
2021
£
£
£
£
Fixed assets
819
Current assets
28,120
61,998
Creditors: amounts falling due within one year
(1,633)
(19,343)
Net current assets
26,487
42,655
Total assets less current liabilities
26,487
43,474
Net assets
26,487
43,474
Capital and reserves
26,487
43,474
Notes to the financial statements
1
Director's benefits: advances, credit and guarantees
At the start of the year, the company owed the director £312 (2021 - £nil). Aggregate advances totalling £2,384 (2021 - £nil) were made to the director. During the year, amounts of £312 (2021 - £312) were repaid by the director, and the balance owed to the company at the year end was £2,384. All advances are informal, interest-free and repayable on demand.
2
Employees
The average number of persons
,
including directors
,
employed by the company during the year wa
s as follows:
2022
2021
Number
Number
Employees
1
2
3
Going concern
The company is expected to be wound up by 31 December 2022, and the accounts have therefore been prepared on a break-up basis.
H2 Medical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is One St. Peter's Square, Manchester, M2 3DE.
For the year ended 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
H2 MEDICAL LTD
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2022
31 March 2022
- 2 -
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and signed by the director and authorised for issue on 21 September 2022
Dr Hashim Al-Gailani
Director
Company Registration Number 11889951